What We Do

Parents Becoming Research Coordinators

By fostering connections between families and leading researchers, Hope for Luka Inc. catalyzes groundbreaking collaborations and accelerates the pace of discovery in the field of Muscular Dystrophy. Moreover, the organization plays a pivotal role in fundraising efforts, empowering parents to initiate independent pre-clinical trials and studies tailored to their children's unique needs.

By tailoring funding to the specific requirements of each stage of a patient's study, we ensure that resources are used efficiently and effectively, maximizing the potential for positive outcomes. This personalized funding model not only aids in advancing scientific research but also highlights the importance of individualized patient care. 

See Our Current Research Pipelines


Funding Research Organizations

Hope for Luka Inc. acts as a bridge between scientific researchers and families seeking potential solutions for their children through supporting relevant research studies. By funding scientific research organizations, enable groundbreaking studies and advancements in understanding unexplored areas of scientific research for less popular mutations (measured based on patient population for each mutation) in Muscular Dystrophy.

Furthermore, by connecting parents with these organizations, we empower patients to take proactive steps in seeking potential treatments or therapies tailored to their children's unique needs. This facilitative approach not only accelerates the pace of research but also fosters a collaborative environment where families and researchers can work together towards common goals, ultimately enhancing the hope and quality of life for those affected by Muscular Dystrophy.

Funding Strategy

Raising capital to fund researchers on a per patient basis is a strategic approach that acknowledges the unique needs of each study participant. This individualized funding model is particularly beneficial in research involving genetic deletions, duplications or nonsense mutations where the variability in patient conditions can significantly influence the resources required at different stages of the study. 

By tailoring the financial support to the specific requirements of each patient, organizations can ensure that researchers have the necessary resources to conduct thorough and personalized investigations. This approach not only enhances the quality and effectiveness of the research but also fosters a more equitable allocation of funds, ultimately contributing to more precise and meaningful scientific outcomes. As you continue to raise capital, it is crucial to communicate the impact of these donations clearly, emphasizing how they directly support the advancement of personalized medical research and, consequently, the betterment of patient care.